Quoin Pharmaceuticals Ltd. SEC filings QNRX
Quoin Pharmaceuticals Ltd. has 584 filings in SEC EDGAR's recent list, going back to Apr 8, 2016. Its latest annual report, Form ARS, was filed on Jul 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 6, 2026 (results of operations).
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Jul 16, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 26, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Jul 17, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 13, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Oct 24, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 14, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Sep 12, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 15, 2023 | Dec 31, 2022 |
| 20-F | Annual report (foreign issuer) | Apr 14, 2022 | Dec 31, 2021 |
| 20-F | Annual report (foreign issuer) | Mar 29, 2021 | Dec 31, 2020 |
| 20-F/A | Amended annual report (foreign issuer) | Aug 4, 2020 | Dec 31, 2019 |
| 20-F | Annual report (foreign issuer) | Apr 3, 2020 | Dec 31, 2019 |
| 20-F | Annual report (foreign issuer) | Mar 18, 2019 | Dec 31, 2018 |
| 20-F | Annual report (foreign issuer) | Mar 19, 2018 | Dec 31, 2017 |
| 20-F | Annual report (foreign issuer) | Mar 23, 2017 | Dec 31, 2016 |
Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- QNRX (Nasdaq)
- Incorporated in
- Israel
- Headquarters
- Ashburn, VA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1671502
- Former names
- Quoin Pharmaceuticals, Ltd. (until Sep 1, 2026); Cellect Biotechnology Ltd. (until Oct 15, 2021); Cellect Biomed Ltd. (until Jul 7, 2016)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.